13045_2020_896_MOESM1_ESM.pdf (408.71 kB)
Additional file 1 of Antibody targeting tumor-derived soluble NKG2D ligand sMIC reprograms NK cell homeostatic survival and function and enhances melanoma response to PDL1 blockade therapy
Version 2 2020-08-27, 12:13
Version 1 2020-06-10, 03:37
journal contribution
posted on 2020-08-27, 12:13 authored by Fahmin Basher, Payal Dhar, Xin Wang, Derek A. Wainwright, Bin Zhang, Jeffrey Sosman, Zhe Ji, Jennifer D. WuAdditional file 1. Supplement Material and Methods. Table S1, Figures S1-S5.
